6-Month Buy/Sell Trend
Buys
Sells
▶
2026-04-09
2 other
▶
2026-02-23
▼ 4 sells
· $229K
⚡ 4 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Dugel Pravin | See Remarks | ▼ Sell | 20,056 | $8 | $166K | Feb 25 | |
| Heier Jeffrey S. | Chief Scientific Officer | ▼ Sell | 3,057 | $8 | $25K | Feb 25 | |
| Kaiser Peter | Chief Development Officer | ▼ Sell | 2,810 | $8 | $23K | Feb 25 | |
| Nayak Sanjay | Chief Strategy Officer | ▼ Sell | 1,759 | $8 | $15K | Feb 25 |
▶
2026-02-20
▲ 1 buy
· $461K
▼ 1 sell
· $27K
⚡ 2 insiders
▶
2026-02-12
▼ 4 sells
· $1.4M
⚡ 4 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Dugel Pravin | See Remarks | ▼ Sell | 124,882 | $9 | $1.1M | Feb 17 | |
| Nayak Sanjay | Chief Strategy Officer | ▼ Sell | 10,348 | $9 | $94K | Feb 17 | |
| Notman Donald | Chief Operating Officer | ▼ Sell | 11,446 | $9 | $103K | Feb 17 | |
| Waheed Nadia | Chief Medical Officer | ▼ Sell | 7,863 | $9 | $71K | Feb 17 |
▶
2026-02-02
▼ 1 sell
· $50K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Notman Donald | Chief Operating Officer | ▼ Sell | 5,455 | $9 | $50K | Feb 4 |
▶
2026-02-04
▼ 1 sell
· $52K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Notman Donald | Chief Operating Officer | ▼ Sell | 6,035 | $9 | $52K | Feb 4 |
▶
2026-01-21
2 other
▶
2026-01-20
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Robins Jason Shand | Interim CFO | A | 33,000 | $0 | $0 | Jan 22 |
▶
2026-01-02
16 other
⚡ 8 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Anderman Todd | Chief Legal Officer | A | 64,900 | $0 | $0 | Jan 6 | |
| Anderman Todd | Chief Legal Officer | A | 197,650 | $0 | $0 | Jan 6 | |
| Heier Jeffrey S. | Chief Scientific Officer | A | 79,112 | $0 | $0 | Jan 6 | |
| Heier Jeffrey S. | Chief Scientific Officer | A | 240,932 | $0 | $0 | Jan 6 | |
| Kaiser Peter | Chief Development Officer | A | 79,112 | $0 | $0 | Jan 6 | |
| Kaiser Peter | Chief Development Officer | A | 240,932 | $0 | $0 | Jan 6 | |
| Meyers Steve Lawrence | Chief Commercial Officer | A | 64,900 | $0 | $0 | Jan 6 | |
| Meyers Steve Lawrence | Chief Commercial Officer | A | 197,650 | $0 | $0 | Jan 6 | |
| Nayak Sanjay | Chief Strategy Officer | A | 64,900 | $0 | $0 | Jan 6 | |
| Nayak Sanjay | Chief Strategy Officer | A | 197,650 | $0 | $0 | Jan 6 | |
| Notman Donald | See Remarks | A | 79,112 | $0 | $0 | Jan 6 | |
| Notman Donald | See Remarks | A | 240,932 | $0 | $0 | Jan 6 | |
| Waheed Nadia | Chief Medical Officer | A | 79,112 | $0 | $0 | Jan 6 | |
| Waheed Nadia | Chief Medical Officer | A | 240,932 | $0 | $0 | Jan 6 | |
| Saroj Namrata | Chief Business Officer | A | 79,112 | $0 | $0 | Jan 6 | |
| Saroj Namrata | Chief Business Officer | A | 240,932 | $0 | $0 | Jan 6 |
▶
2025-11-24
▼ 4 sells
· $336K
⚡ 4 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Dugel Pravin | See Remarks | ▼ Sell | 19,530 | $12 | $235K | Nov 26 | |
| Heier Jeffrey S. | Chief Scientific Officer | ▼ Sell | 3,469 | $12 | $42K | Nov 26 | |
| Kaiser Peter | Chief Development Officer | ▼ Sell | 3,007 | $12 | $36K | Nov 26 | |
| Nayak Sanjay | Chief Strategy Officer | ▼ Sell | 1,878 | $12 | $23K | Nov 26 |
▶
2025-11-26
2 other
▶
2025-11-05
▼ 1 sell
· $278K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Saroj Namrata | Chief Business Officer | ▼ Sell | 25,865 | $11 | $278K | Nov 7 |